Brief: Poolbeg Pharma PLC Gets Notice Of Allowance For Significant POLB 001 Patent In United States
20/03/2024 07:22
March 20 (Reuters) - Poolbeg Pharma PLC POLB.L :
* NOTICE OF ALLOWANCE FOR SIGNIFICANT POLB 001 PATENT IN
UNITED
STATES
Source text for Eikon: ID:nRST4981Ha
Further company coverage: POLB.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Poolbeg Pharma
See all newsBrief: Poolbeg Pharma Says European Patent Granted For POLB 001 In CRS
PDMR Notification
Brief: Poolbeg Pharma Says FDA Feedback Broadly Aligned With Development Pathway For POLB 001
Brief: Poolbeg Pharma Announces Granted POLB 001 Cancer Immunotherapy-Induced CRS Patent In Canada
Annual Report & AGM Notice